DAVE Dave Inc./DE Insider Trading

CFO/COO/Secretary Kyle Beilman sells 4,122 shares at $275.03 avg for $1,133,659.27; retains 196,155 shares.

Kyle Beilman, CFO and COO and Secretary, executed 2 separate sales totaling 4,122 shares for $1,133,659.27 on 2026-06-02, reducing holdings by 2.1% to 196,155 shares. His 5 prior sells at DAVE have all been well-timed at the 90-day mark, with negative 90-day returns on each occasion—a consistent pattern suggesting disciplined execution. The current stock price of $261.69 is now 11.0% below the 52-week high of $293.90, placing these transactions at a level higher than today's valuation. With the company posting revenue growth of 59.7% annually and net income of $57,936,000.00 on the latest quarter's $158,414,000.00 revenue, near-term fundamentals remain solid; the 90-day window following this sale will clarify whether the pattern of well-timed exits at this ticker continues.

CEO Jason Wilk sells 8,474 shares for $2.3M at avg $275.05; stock now $261.69; prior DAVE trades 5-of-5 well-timed at 90-day mark.

Jason Wilk, CEO of Dave Inc./DE, executed three separate sales on 2026-06-02 totaling 8,474 shares for $2,330,793.30 at a blended average price of $275.05, reducing his holdings from 308,424 to 299,950 shares. The transaction occurred when the stock was trading near its 52-week high (current price $261.69 is -11.0% from the $293.90 peak), and notably, all five of Wilk's prior sales at this ticker were well-timed at the 90-day mark (post-sale declines ranging from -2.3% to -14.1%), suggesting a consistent pattern of selling ahead of downturns specific to DAVE. The fundamental picture is strong—Dave posted $158.4M in revenue, $57.9M net income, and +59.7% annual revenue growth with a 17.86 P/E—yet the CEO's repeated pattern of selling before losses and the -0.8% deterioration over 30 days warrants attention to whether this sale reflects a discretionary view on near-term valuation or momentum.

Director Mitchell Andrea sold 30,000 shares in 26 separate transactions for $6.4M under pre-arranged 10b5-1 plan.

Mitchell Andrea, a director of Dave Inc./DE (DAVE), executed 26 separate sales over two trading days (March 5-6, 2026) totaling 30,000 shares for $6,390,900.55 at a blended average price of $213.03. This represents a reduction of 82.2% of her pre-transaction holdings (from 36,509 shares to 6,509 shares). The filing explicitly flags this activity as part of a pre-arranged 10b5-1 trading plan adopted on 2025-11-30, meaning the sales were scheduled rather than discretionary. While the dollar magnitude ($6.4M) and share volume (30.0K shares) are substantial, the scheduled nature of the plan removes inferences about timing conviction or market outlook, and investors should note the substantial reduction in the director's residual stake.

Director Khan Imran sold 36,378 shares for $7,255,860.00 via 10b5-1 plan (scheduled, 2025-12-17/18).

Khan Imran, a director of Dave Inc., executed 30 separate sales totaling 36,378 shares for $7,255,860.00 across 2025-12-17 and 2025-12-18 at blended average price $199.46. This disposition reduces his holdings by -96.9% from 37,524 shares to 1,146 shares post-transaction. The FLAG indicates this activity is part of a pre-arranged 10b5-1 trading plan adopted 2025-03-14, meaning the sales were scheduled in advance rather than discretionary. The near-complete liquidation of a director's position warrants attention to whether this reflects confidence constraints or planned portfolio management established months prior.

Director Khan Imran sold 18,835 shares for $3.7M under pre-arranged 10b5-1 plan on 2025-12-16, reducing stake by 50.1% to 18,735 shares

Khan Imran executed 11 separate sales totaling 18,835 shares for $3,709,407.12 across multiple price points ranging from $189.54 to $199.06, with a blended average price of $196.94. This transaction reduced his holdings by approximately half, from 37,570 to 18,735 shares. The sales were conducted pursuant to a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, meaning the timing and quantities were scheduled in advance rather than discretionary decisions made on 2025-12-16. Investors should note that the magnitude of this sale—eliminating half his position—combined with the systematic execution across multiple price levels reflects the mechanics of a predetermined liquidation schedule rather than a response to current market conditions.

Director Khan Imran sold 41,412 shares for $7,995,332.87 via pre-arranged 10b5-1 plan on 2025-12-15 to 2025-12-16.

Director Khan Imran executed 30 separate sales totaling 41,412 shares for $7,995,332.87 across December 15–16, 2025, reducing his holdings from 64,298 shares to 22,886 shares. This transaction was part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-14, meaning the sales were scheduled rather than discretionary. The blended average price of $193.07 across the multiple tranches reflects execution at varied price levels within a narrow intraday band. Because the sales followed a pre-determined schedule established months earlier, they do not reflect a real-time directional signal about current conditions or the director's present conviction regarding the stock. Investors should note the scale of the reduction (64.4% of pre-transaction holdings) but recognize this magnitude was committed to in March, not a fresh decision in December.

CFO Beilman Kyle sold 3,495 shares of DAVE at $203.77; retains 150,556 shares (-2.3% holdings)

Beilman Kyle, serving as CFO and COO and Secretary, sold 3,495 shares on 2025-12-02 at $203.77, reducing his holdings from 154,051 to 150,556 shares—a modest -2.3% reduction in his stake. The sale occurred at a price 27.7% below the 52-week high of $281.79 and follows a 15.1% decline over the preceding 30 days. At the same ticker, his prior five trades have shown mixed timing outcomes, with only one measurable 90-day result (the 2025-09-04 sale, which posted a +1.6% return—meaning the stock rose after his sale, rendering that trade poorly timed). His broader cross-ticker track record shows 20 prior sells with an average 90-day return of +2.9%, indicating a 18.75% well-timed rate—modestly below-average at capturing declines. Dave Inc. fundamentals remain strong, with revenue of $150,725,000.00 and net income of $92,072,000.00 in the latest quarter, paired with 34.0% annual revenue growth and a P/E of 44.11.

DAVE CEO Wilk Jason sold 7,393 shares at $203.77 on 2025-12-02; holds 210,461 shares post-trade.

CEO Jason Wilk sold 7.4K shares (3.4% of his pre-transaction holdings) at $203.77, reducing his position to 210.5K shares. The current price of $203.77 is 27.7% below the 52-week high of $281.79 and down 15.1% over the past 30 days, placing the trade in a period of recent weakness. His prior trades at DAVE show a mixed timing pattern: four of the five prior sales (executed in early-to-mid September) occurred before subsequent declines of 4.1% to 15.2% over 30 days, while one sale on 2025-09-04 was followed by a gain of 2.2% at the 90-day mark. His cross-ticker selling history shows an average 90-day return of +3.2% post-sale, indicating that on average his sells across all tickers have not preceded declines. The company reports strong fundamentals with $150.7M quarterly revenue, $92.1M net income, and 34.0% annual revenue growth, but trades at a P/E of 44.11. The combination of recent stock weakness, mixed timing outcomes at this ticker, and fundamentally solid but richly-valued company metrics warrants attention to whether this sale reflects conviction in valuations or simply routine portfolio management.

CFO Kyle Beilman sells 59,541 shares of DAVE for $13,698,378.46 via pre-arranged 10b5-1 plan

Kyle Beilman, CFO and COO of Dave Inc., executed 2 separate sales totaling 59,541 shares for $13,698,378.46 at a blended average price of $230.07 on 2025-09-19. This sale reduced his post-transaction holdings to 154,051 shares, down 27.9% from pre-transaction holdings of 213,592 shares. The transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-06-04, indicating the sales were scheduled rather than discretionary. As a scheduled program, this transaction does not provide insight into management's current market assessment, but the cumulative reduction of holdings by more than one-quarter warrants investor attention to the underlying business fundamentals and forward guidance.

DAVE CEO Wilk Jason sells 81,693 shares for $18,812,564.17 via scheduled 10b5-1 plan

CEO Jason Wilk executed 2 separate sales totaling 81,693 shares for $18,812,564.17 at an average price of $230.28 on 2025-09-19, reducing holdings from 299,547 shares to 217,854 shares (a 27.3% reduction). The sales were conducted under a pre-arranged 10b5-1 trading plan adopted on 2025-05-30, making them scheduled transactions rather than discretionary trades. While the magnitude of the sale represents a substantial reduction in the CEO's position, the pre-arranged nature of the plan prevents attribution to any particular market view or confidence signal. This transaction is disclosed in the Form 4 filing and should be monitored in the context of Dave Inc.'s broader financial performance and market conditions.